<DOC>
	<DOC>NCT00159380</DOC>
	<brief_summary>The primary aim of this study is to investigate the effects of oral and inhaled administration of L-arginine and of inhaled aminoguanidine on bronchial and alveolar exhaled NO and NO metabolites in exhaled breath condensate, saliva and nasal lavage fluid in normal and asthmatic subjects.</brief_summary>
	<brief_title>Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pimagedine</mesh_term>
	<criteria>Healthy nonsmokers (n=10): Nonatopic subjects (exhaled NO greater than or equal to 10 ppb; flow 50 ml/s) Normal spirometry Able to comprehend and grant a written informed consent Asthmatic subjects (n=15): Forced expiratory volume in one second (FEV1) of no less than 70% of predicted (exhaled NO greater than or equal to 15 ppb; flow 50 ml/s) Clinically stable (steroidna√Øve or taking no &gt; 600 mcg/day of inhaled steroids) Able to comprehend and grant a written informed consent Currently smoking Any lung disease other than asthma which may interfere with the study Treatment within the last 4 weeks with oral steroids Respiratory infection within 4 weeks prior to entry into the trial Females who are pregnant or lactating History of current or past drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>